J&K covered 60 per cent of beneficiary families within 6 months of Ayushman Bharat

Published On 2019-10-06 03:30 GMT   |   Update On 2019-10-06 03:30 GMT

"Jammu and Kashmir covered 60 per cent of the beneficiary families, with regard to golden card generation, in less than first six months of its implementation.New Delhi: Jammu and Kashmir has been accorded the 'best learning and sharing space' award during an event held here to mark one year of the Ayushman Bharat scheme, an official statement said. "Jammu and Kashmir covered 60 per cent of...

Login or Register to read the full article
"Jammu and Kashmir covered 60 per cent of the beneficiary families, with regard to golden card generation, in less than first six months of its implementation.

New Delhi: Jammu and Kashmir has been accorded the 'best learning and sharing space' award during an event held here to mark one year of the Ayushman Bharat scheme, an official statement said. "Jammu and Kashmir covered 60 per cent of the beneficiary families, with regard to golden card generation, in less than first six months of its implementation.

Also read:- 111 defaulter Hospitals of Ayushman Bharat to be Publicly named and shamed on website: Dr Harsh Vardhan

"The innovative practices adopted by the state in generation of golden cards resulted in better utilisation of services by the beneficiaries," the statement said.

The state got the best learning and sharing space award during the event 'Arogya Manthan' held here, it said.

An event to mark one year of the flagship health insurance programme was held here and was addressed by Prime Minister Narendra Modi.

Also read:- PM Modi to unveil updated version of Ayushman Bharat app on Oct 1

Financial commissioner for health and medical education, Atal Dulloo, and chief executive officer (CEO) of the JK health agency, Bhupinder Kumar, received the award from Union Health and Family Welfare Minister Harshvardhan at Vigyan Bhawan, it said.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News